Analgesic Effect Between TAP Block and Continuous Wound Infusion in Abdominoplasty Surgery
- Conditions
- Surgery of Abdominoplasty With Flank Liposuction
- Interventions
- Procedure: Transverse abdominal plan blockProcedure: Continuous wound infusion
- Registration Number
- NCT01862354
- Lead Sponsor
- University of Liege
- Brief Summary
The purpose of this randomized controlled study is to compare the postoperative analgesic effect of a continuous wound infusion of local anesthetics and a sole transverse abdominal plan (TAP) regional block in the surgery of Abdominoplasty Combined With Flank Liposuction. Local anesthetics products used are ropivacaine combined with clonidine. Similar amount of local anesthetics and clonidine are used.
- Detailed Description
In a first group, patients receive, after induction of anaesthesia and before surgery, a TAP block (transverse abdominal plan block) with 3mg/kg Ropivacaine 0.5% (maximum 200 mg) and 150 microg Clonidine.
In a second group, before skin closure, a multiholes catheter was inserted beyond the skin. 20 mg Ropivacaine 0.2% added with 150 microg Clonidine was injected as bolus dose through this catheter followed by a continuous infusion of Ropivacaine 0.2% 10ml per hour during the following 9 hours (total dose of 200 mgr).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 50
- Patients scheduled for abdominoplasty combined with flank liposuction
- Allergy to local anesthetics or clonidine
- Coagulation disorders
- History of chronic pain
- Alcohol or drugs dependance
- Refusal of the patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group TAP block Transverse abdominal plan block Patients in this group received a transverse abdominal plan block with local anesthetics and clonidine as postoperative analgesia. Group : Continuous wound infusion Continuous wound infusion Patients in this group received continuous wound infusion with local anesthetics and clonidine as postoperative analgesia.
- Primary Outcome Measures
Name Time Method Pain score expressed on a visual analogue scale at 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively
- Secondary Outcome Measures
Name Time Method Piritramide consumption on Patient Controlled Analgesia (PCA) device at 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively Scale of nausea at 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively Scale of nausea was defined as :
0 = No nausea - 1 = weak nausea - 2 = Moderate nausea - 3 = Important nauseaScale of sedation at 0,2,4,6, 8 hours, and day 1 and day 2 postoperatively Scale of sedation was defined as :
0 = Awake patient - 1 = Quiet and awake - 2 = Sleepy but arousable - 3 = Sleepy and not arousableScale of patient's satisfaction at day 2 postoperatively Scale of satisfaction was defined as :
1 = Very satisfied - 2 = Satisfied with no enthusiasm - 3 = Not satisfiedNumber of patients with adverse events daily during 48 hours postoperatively
Trial Locations
- Locations (1)
University of Liege, University Hospital
🇧🇪Liege, Belgium